Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease
Yuanming Li, Jing Zhang, Jiale Wan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110887-110887
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 320
Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies
Umair Shabbir, Muhammad Sajid Arshad, Aysha Sameen, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 690-690
Open Access | Times Cited: 139
Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Jesús Burillo, Patricia Marqués, Beatriz Jiménez, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1236-1236
Open Access | Times Cited: 131
Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
Teresa Pardo-Moreno, Anabel González‐Acedo, Antonio Rivas-Domínguez, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1117-1117
Open Access | Times Cited: 128
The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 86
Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
Deanna M. Minich, Melanie Henning, Catherine Darley, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 3934-3934
Open Access | Times Cited: 84
Tetrahydroxy stilbene glycoside ameliorates Alzheimer’s disease in APP/PS1 mice via glutathione peroxidase related ferroptosis
Yan Gao, Juntong Li, Qing-lin Wu, et al.
International Immunopharmacology (2021) Vol. 99, pp. 108002-108002
Closed Access | Times Cited: 64
A Growing Link between Circadian Rhythms, Type 2 Diabetes Mellitus and Alzheimer’s Disease
Xuemin Peng, Rongping Fan, Lei Xie, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 504-504
Open Access | Times Cited: 41
Neuroprotective Effects of Phytochemicals against Aluminum Chloride-Induced Alzheimer’s Disease through ApoE4/LRP1, Wnt3/β-Catenin/GSK3β, and TLR4/NLRP3 Pathways with Physical and Mental Activities in a Rat Model
Ahmed M. Hamdan, Fatimah Hussain J. Alharthi, Ahmed Hadi Alanazi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1008-1008
Open Access | Times Cited: 41
Zinc in Cognitive Impairment and Aging
Ruize Sun, Jue Wang, Juan Feng, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 1000-1000
Open Access | Times Cited: 39
Importance of Bmal1 in Alzheimer's disease and associated aging‐related diseases: Mechanisms and interventions
Rongping Fan, Xuemin Peng, Lei Xie, et al.
Aging Cell (2022) Vol. 21, Iss. 10
Open Access | Times Cited: 38
Brain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm
Rüssel J. Reiter, Ramaswamy Sharma, Maira Smaniotto Cucielo, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 4
Closed Access | Times Cited: 28
The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
Wenjun Cai, Tong Wu, Ning Chen
Biomolecules (2023) Vol. 13, Iss. 2, pp. 313-313
Open Access | Times Cited: 27
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
Christopher D. Morrone, Radha Raghuraman, S. Abid Hussaini, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 27
Melatonin reduces β-amyloid accumulation and improves short-term memory in streptozotocin-induced sporadic Alzheimer’s disease model
Marcos K. Andrade, Leonardo C. Souza, Evellyn M. Azevedo, et al.
IBRO Neuroscience Reports (2023) Vol. 14, pp. 264-272
Open Access | Times Cited: 24
Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102119-102119
Closed Access | Times Cited: 24
Dysfunction of circadian and sleep rhythms in the early stages of Alzheimer's disease
Ludovica Rigat, Koliane Ouk, Achim Kramer, et al.
Acta Physiologica (2023) Vol. 238, Iss. 2
Open Access | Times Cited: 23
AMPA receptor neurotransmission and therapeutic applications: A comprehensive review of their multifaceted modulation
Mohammad Qneibi, Sosana Bdir, Mohammad Bdair, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116151-116151
Closed Access | Times Cited: 14
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease
Tao Zhang, Byeong Mo Kim, Tae Ho Lee
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Protective Effect of the Novel Melatonin Analogue Containing Donepezil Fragment on Memory Impairment via MT/ERK/CREB Signaling in the Hippocampus in a Rat Model of Pinealectomy and Subsequent Aβ1-42 Infusion
Jana Tchekalarova, Petya Ivanova, Desislava Krushovlieva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1867-1867
Open Access | Times Cited: 8
Protective effect of melatonin against metabolic disorders and neuropsychiatric injuries in type 2 diabetes mellitus mice
Xinran Gao, Huaizhi Sun, Yadong Wei, et al.
Phytomedicine (2024) Vol. 131, pp. 155805-155805
Closed Access | Times Cited: 8
Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway
Ji-Ji Dao, Wei Zhang, Chong Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
New Possibilities in the Therapeutic Approach to Alzheimer’s Disease
Julia Doroszkiewicz, Barbara Mroczko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8902-8902
Open Access | Times Cited: 28
Research Evidence of the Role of the Glymphatic System and Its Potential Pharmacological Modulation in Neurodegenerative Diseases
Joji Philip Verghese, Alana Terry, Edoardo Rosario de Natale, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6964-6964
Open Access | Times Cited: 28
Electrochemical Immunosensors Developed for Amyloid-Beta and Tau Proteins, Leading Biomarkers of Alzheimer’s Disease
Abhinav Sharma, Lúcio Angnes, N. Sattarahmady, et al.
Biosensors (2023) Vol. 13, Iss. 7, pp. 742-742
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top